Authors: Mentre, F Dubruc, C Thenot, JP

Citation: F. Mentre et al., Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children, J PHARMA PH, 28(3), 2001, pp. 299-319

Authors: Deschamps, C Dubruc, C Mentre, F Rosenzweig, P

Citation: C. Deschamps et al., Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model, CLIN PHARM, 68(6), 2000, pp. 647-657

Authors: Chaufour, S Caplain, H Lilienthal, N L'Heritier, C Deschamps, C Dubruc, C Rosenzweig, P

Citation: S. Chaufour et al., Study of cardiac repolarization in healthy volunteers performed with mizolastine, a new H-1-receptor antagonist, BR J CL PH, 47(5), 1999, pp. 515-520

Authors: Rosenzweig, P Patat, A Curet, O Durrieu, G Dubruc, C Zieleniuk, I Legangneux, E

Citation: P. Rosenzweig et al., Clinical pharmacology of befloxatone: a brief review, J AFFECT D, 51(3), 1998, pp. 305-312